Re: Increased risk of cancer in Lantus-treated patients
[ Follow-Ups ]
[ Post Followup ]
[ The Islet Foundation Public Message Forum ]
Posted by Edward T on 12:32:45 2009/06/27
In Reply to:
Re: Increased risk of cancer in Lantus-treated patients posted by Christian
If I understand correctly, it is only Lantus (or Lantus-type long-acting insulins) in question? The fast-acting Novolog isn't under suspicion?
So worst-case scenario is a person would drop the Lantus and go back to something like the older "N" synthetic human insulin and inject twice a day because it only has a 12-hour duration?
Was the 24-hour duration the only advantage with Lantus? I'm not bothered by the extra injection.
Follow Ups:
Post a Followup
[ Follow Ups ]
[ Post Followup ]
[ The Islet Foundation Public Message Forum ]